BPC-157 + TB-500 (5mg/5mg)

Description

BPC-157 + TB-500

Lyophilized Powder | Third-Party Tested | USA-Manufactured

In Stock | Free Shipping on Orders Over $150

---

Product Specifications

• Peptide Name: BPC-157 + TB-500
• Molecular Formula: Not provided
• Molecular Weight: Not provided
• CAS Number: Not provided
• Sequence:
• BPC-157: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
• TB-500: Synthetic peptide corresponding to a thymosin beta fragment
• Purity: ≥99% (HPLC verified)
• Form: Lyophilized powder (combined vial)
• Storage: -20°C (long-term) | 2–8°C (short-term) | Protect from light
• Shelf Life: Up to 12 months when stored sealed and dry

---

Compound Overview

BPC-157 + TB-500 is a combined-vial peptide formulation composed of two distinct synthetic research peptides: BPC-157, a short linear peptide sequence, and TB-500, a synthetic peptide corresponding to a thymosin beta fragment. Structurally, this blend represents a dual-peptide system with differing sequence classes and molecular frameworks used in experimental peptide characterization.

In laboratory research contexts, blended peptide formats such as BPC-157 + TB-500 are evaluated for identity confirmation, stability profiling, and analytical separation of component peptides using chromatographic and mass spectrometry workflows. Experimental literature describes each component peptide class within controlled in vitro and preclinical animal model settings. All data referenced on this page is derived from published preclinical animal and in vitro studies. No human clinical trials have established approved uses for BPC-157 + TB-500 as a research compound.

---

Published Preclinical Research

Published literature describes BPC-157 and thymosin beta–derived peptide fragments as defined research compounds investigated within controlled experimental systems.

• Structural characterization of peptide components using chromatographic and mass spectrometry identity workflows
• Peptide stability and degradation profiling of short synthetic peptide sequences in biological matrices
• Comparative evaluation of peptide fragment classes in controlled in vitro and preclinical research models
• Analytical method development for multi-peptide formulations in laboratory testing environments

All data referenced on this page is derived from published preclinical animal and in vitro studies. No human clinical trials have established approved uses for BPC-157 + TB-500.

---

Research Applications

• Dual-peptide identity confirmation using LC-MS workflows
• Method development for separating and quantifying blended peptide components
• Peptide stability and degradation profiling under controlled conditions
• Comparative analytical evaluation of short synthetic peptide fragment classes
• Preclinical peptide research using validated in vitro and animal model systems

---

Physical Specifications

• Vial Size: 3 mL sterile vial
• Fill: 5mg BPC-157 + 5mg TB-500
• Appearance: White to off-white lyophilized powder
• Reconstitution Volume: Researcher-determined under validated laboratory protocols
• Post-Reconstitution Storage: 2–8°C, use within 30 days
• Solubility: Water-based laboratory solvents

---

Compare to Related Compounds

BPC-157

• The BPC-157 + TB-500 blend contains BPC-157 as one component peptide, whereas BPC-157 (10mg) is supplied as a single-peptide vial with the same peptide sequence class.
• Single-peptide and blended-peptide formats are differentiated in laboratory workflows by analytical separation requirements and component verification steps.

TB-500

• The BPC-157 + TB-500 blend contains TB-500 as one component peptide, whereas TB-500 (10mg) is supplied as a standalone peptide vial corresponding to a thymosin beta fragment.
• Analytical characterization focuses on confirming identity of each component peptide and verifying purity within blended or single-compound preparations.

GLOW (BPC-157 + TB-500 + GHK-Cu)

• BPC-157 + TB-500 is a two-peptide combined-vial formulation, whereas GLOW is a combination vial containing BPC-157, TB-500, and GHK-Cu as an additional peptide component.
• Multi-peptide formulations are differentiated in laboratory workflows by component count, analytical separation requirements, and multi-analyte identity confirmation methods.

---

Handling & Storage

Lyophilized Stability:
When stored sealed in a dry environment protected from light, lyophilized peptide material may maintain chemical stability for up to 12 months at controlled room temperature. For maximum long-term preservation, storage at -20°C is recommended.

Post-Reconstitution Stability:
Following reconstitution under sterile laboratory conditions, the solution may maintain stability for up to 30 days when stored at 2–8°C. Minimize repeated freeze–thaw cycles and protect from light to preserve peptide integrity.

Handling:
Allow vial to equilibrate to room temperature before opening to prevent moisture condensation. Use sterile technique throughout preparation.

---

Certificate of Analysis & Third-Party Testing

Every batch of BioEdge BPC-157 + TB-500 undergoes independent third-party testing prior to release. Testing is performed by ISO-accredited laboratories with results available on each product page.

Identity Confirmation	Mass Spectrometry (MS)
Purity Assessment	High-Performance Liquid Chromatography (HPLC)
Minimum Purity Acceptance	≥99%
Heavy Metals	ICP-MS panel
Sterility	USP <71> Sterility Testing
COA Format	Batch-specific test results, downloadable on product page

To view testing results, scroll to the 3rd Party Testing section located below the product image.

---

Why Researchers Choose BioEdge for BPC-157 + TB-500

Batch-specific COA from an independent lab. Not a generic PDF recycled across products. Every vial of BPC-157 + TB-500 is backed by independent third-party laboratory testing, with a Certificate of Analysis available for review on our product page. HPLC confirms purity. Mass spectrometry confirms molecular identity. The COA corresponds to the specific batch you receive.

USA lyophilization. Many vendors import pre-filled vials from overseas and relabel them. BioEdge sources API and performs lyophilization within the United States, maintaining direct quality control over the final product.

No filler compounds. BioEdge BPC-157 + TB-500 is pure lyophilized peptide. No mannitol, no bulking agents, no unnecessary excipients.

Same-day shipping. Domestic orders placed before 3pm ship the same day. Free shipping on orders over $150.

---

Frequently Asked Questions

What is BPC-157 + TB-500?

BPC-157 + TB-500 is a combined-vial peptide formulation containing two synthetic research peptides supplied exclusively for laboratory research use.

What is the CAS number for BPC-157 + TB-500?

Not provided

How should BPC-157 + TB-500 be stored?

Store sealed in a dry environment protected from light. For maximum long-term preservation, storage at -20°C is recommended.

Is BPC-157 + TB-500 third-party tested?

Yes. Every batch undergoes independent third-party testing prior to release.

Where can I access the COA for BPC-157 + TB-500?

COAs are available below the product image in the 3rd Party Testing section on the product page.

Is BPC-157 + TB-500 FDA approved?

BioEdge BPC-157 + TB-500 is sold strictly as a research compound for in vitro laboratory use. It has not been evaluated or approved by the FDA for any human use in this form. All products sold by BioEdge Research Labs are for laboratory and research purposes only.

Do you ship BPC-157 + TB-500 within the USA?

Yes. BioEdge Research Labs is a USA based supplier with same day domestic shipping on orders placed before 3pm Eastern. Free shipping on orders over $150.

Can I get bulk pricing on BPC-157 + TB-500?

Yes. Contact BioEdge Research Labs directly for institutional and bulk research pricing.

---

Published References

1. Sikiric P, et al. “Pentadecapeptide BPC 157 and the Central Nervous System.” NeuroRegulation. 2022;9(1):57-68. Link

2. Jaric S, et al. “BPC 157 and its effects in gastrointestinal, vascular, and nervous system contexts.” Current Neuropharmacology. 2016;14(8):723-731. Link

3. Li F, et al. “Thymosin Beta-4 and TB-500 research: Investigations in tissue dynamics and cellular responses.” Peptide Science Journal. 2024;110(2):e24412. Link

---

RESEARCH USE ONLY Disclaimer

RESEARCH USE ONLY. BPC-157 + TB-500 is sold exclusively for in vitro laboratory and research purposes. This product is not intended for human or animal consumption, clinical use, or therapeutic application. It has not been evaluated by the Food and Drug Administration (FDA) for safety, efficacy, or any medical purpose. Purchase and use of this product confirms the buyer will use it only in qualified research settings, in compliance with all applicable federal, state, and local regulations. BioEdge Research Labs is a chemical supplier, not a compounding pharmacy or clinical facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. BioEdge Research Labs makes no claims regarding therapeutic, diagnostic, or clinical applications of this compound.